Company registration number 10894475 (England and Wales)
MEDSCHECK LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025
PAGES FOR FILING WITH REGISTRAR
MEDSCHECK LTD
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 9
MEDSCHECK LTD
BALANCE SHEET
AS AT
31 AUGUST 2025
31 August 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
3
2,206,479
2,343,271
Tangible assets
4
329,515
159,713
Investment property
5
1
1
2,535,995
2,502,985
Current assets
Stocks
270,420
210,419
Debtors
6
1,464,479
917,377
Cash at bank and in hand
13,256
199,203
1,748,155
1,326,999
Creditors: amounts falling due within one year
7
(1,840,196)
(1,761,620)
Net current liabilities
(92,041)
(434,621)
Total assets less current liabilities
2,443,954
2,068,364
Creditors: amounts falling due after more than one year
8
(2,681,644)
(2,311,269)
Provisions for liabilities
(36,777)
-
Net liabilities
(274,467)
(242,905)
Capital and reserves
Called up share capital
1
1
Profit and loss reserves
(274,468)
(242,906)
Total equity
(274,467)
(242,905)
MEDSCHECK LTD
BALANCE SHEET (CONTINUED)
AS AT
31 AUGUST 2025
31 August 2025
- 2 -

For the financial year ended 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 19 May 2026
Mr N Amin
Director
Company registration number 10894475 (England and Wales)
MEDSCHECK LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025
- 3 -
1
Accounting policies
Company information

Medscheck Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Unit 3-4 133 Brockhurst Road, Gosport, Hampshire, England, PO12 3AX.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Going concern

The company has net current assets of £2,443,954 (2024 net current assets: £2,068,364) and net liabilities of £274,467 (2024 net liability : £242,905). Director has confirmed that they will support the company to meet its liabilities and obligations for at least twelve months from the date of approval of these financial statements. For this reason, the director continue to adopt the going concern basis in preparing the financial statements.true

1.3
Revenue

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

 

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.4
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 20 years.

 

For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

MEDSCHECK LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
1
Accounting policies
(Continued)
- 4 -
1.5
Intangible fixed assets other than goodwill

Director has decided not to amortise other intangible assets as its value is trivial.

Other intangible assets
Not amortised
1.6
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold land and buildings
Not amortised
Fixtures and fittings
20% straight line
Computers
25% straight line
Motor vehicles
25% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Director has decided not to provide any depreciation on lease hold property.

1.7
Investment property

Investment property, which is property held to earn rentals and/or for capital appreciation, is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value at the reporting end date. Changes in fair value are recognised in profit or loss.

1.8
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.9
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

MEDSCHECK LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
1
Accounting policies
(Continued)
- 5 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.13
Leases
As lessee

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

As lessor

Rental income from operating leases is recognised on a straight line basis over the term of the relevant lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised on a straight line basis over the lease term.

1.14

Related party exemption

The company has taken advantage of the exemption, under the terms of Financial Reporting Standard 102,' The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

MEDSCHECK LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 6 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
46
34
3
Intangible fixed assets
Goodwill
Other intangible assets
Total
£
£
£
Cost
At 1 September 2024 and 31 August 2025
2,735,836
6
2,735,842
Amortisation and impairment
At 1 September 2024
392,571
-
0
392,571
Amortisation charged for the year
136,792
-
0
136,792
At 31 August 2025
529,363
-
0
529,363
Carrying amount
At 31 August 2025
2,206,473
6
2,206,479
At 31 August 2024
2,343,265
6
2,343,271
4
Tangible fixed assets
Leasehold land and buildings
Fixtures and fittings
Computers
Motor vehicles
Total
£
£
£
£
£
Cost
At 1 September 2024
602
175,489
4,942
115,980
297,013
Additions
141,885
109,751
6,923
-
0
258,559
At 31 August 2025
142,487
285,240
11,865
115,980
555,572
Depreciation and impairment
At 1 September 2024
-
0
75,395
3,082
58,823
137,300
Depreciation charged in the year
-
0
57,048
2,714
28,995
88,757
At 31 August 2025
-
0
132,443
5,796
87,818
226,057
Carrying amount
At 31 August 2025
142,487
152,797
6,069
28,162
329,515
At 31 August 2024
602
100,094
1,860
57,157
159,713
MEDSCHECK LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
4
Tangible fixed assets
(Continued)
- 7 -

Included within the net book value of the above asset is £28,162 (2024: £57,157) relating to assets held under hire purchase agreements. The depreciation charged in the year in respect of such assets amounted to £28,995 (2024: 28,995).

5
Investment property
2025
£
Fair value
At 1 September 2024 and 31 August 2025
1

Medscheck Ltd holds 50% of the share capital of LP SD One Hundred Seven Limited.

6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
464,208
346,421
Other debtors
1,000,271
570,956
1,464,479
917,377
7
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
116,446
299,739
Trade creditors
582,515
751,371
Amounts owed to group undertakings
-
0
21,416
Taxation and social security
38,022
11,761
Other creditors
1,103,213
677,333
1,840,196
1,761,620
MEDSCHECK LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 8 -
8
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans and overdrafts
2,626,692
2,240,456
Other creditors
54,952
70,813
2,681,644
2,311,269
Creditors which fall due after five years are payable as follows:
Payable other than by instalments
2,143,923
2,142,763

The bank loans and overdrafts falling due within one year and after more than one year are secured by a fixed and floating charge over the assets of the company.

 

The following assets are held as security and are charged to Lloyds Bank plc:

 

1) An all moneys guarantee from Mr N Amin for a principal amount of £1,365,000 plus interest and other costs as detailed in the guarantee together with such other security as the Bank may from time to time hold in respect of the debts and liabilities of the guarantor to the Bank.

 

2) An unlimited debenture from Medscheck Ltd.

 

3) A first legal charge from Medscheck Ltd over the leasehold land and buildings at Brockhurst Pharmacy, 135 Brockhurst Road, Gosport, PO12 3AX; 10 Rowner Road, Gosport, PO13 0EW; 78 Brighton Road, Worthing, BN11 2EN; and 135 Highlands Road, Fareham, PO15 6HZ.

 

4) An assignment of the proceeds of a life insurance policy of not less than £2,000,000 which is to be taken out in respect of Mr N Amin with assurers acceptable to the Bank.

 

5) An omnibus guarantee and set off agreement among the Bank, Medscheck Ltd, Medscheck Sub 1 Ltd, Medscheck Sub 1 Property Ltd and Brockhurst Road Property Ltd together with such other security as the Bank may from time to time hold in respect of the debts and liabilities of any guarantor to the Bank.

9
Finance lease obligations
2025
2024
Amounts due:
£
£
Within one year
17,902
17,902
After more than one year
54,952
70,813
72,854
88,715
MEDSCHECK LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
9
Finance lease obligations
(Continued)
- 9 -
2025
2024
Future minimum lease payments due:
£
£
Within one year
17,902
17,902
In two to five years
54,952
70,813
72,854
88,715

The amounts due under finance lease obligation has a fixed interest rate and is secured by the company over the asset held under hire purchase lease agreements.

10
Operating lease commitments
As lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2025
2024
£
£
Total commitments
609,849
473,682
11
Related party transactions
Transactions with related parties

During the year the company entered into the following transactions with related parties:

The following amounts were outstanding at the reporting end date:

2025
2024
Amounts due from related parties
£
£
Entities with common controlling shareholders and directors
784,802
315,962

The above disclosed amount is included within the other debtors due in one year. The loan is unsecured, interest free and repayable on demand.

2025-08-312024-09-01falsefalsefalse19 May 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityMr N Amin108944752024-09-012025-08-31108944752025-08-31108944752024-08-3110894475core:Goodwill2025-08-3110894475core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2025-08-3110894475core:Goodwill2024-08-3110894475core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2024-08-3110894475core:FurnitureFittings2025-08-3110894475core:ComputerEquipment2025-08-3110894475core:MotorVehicles2025-08-3110894475core:LandBuildings2024-08-3110894475core:FurnitureFittings2024-08-3110894475core:ComputerEquipment2024-08-3110894475core:MotorVehicles2024-08-3110894475core:CurrentFinancialInstrumentscore:WithinOneYear2025-08-3110894475core:CurrentFinancialInstrumentscore:WithinOneYear2024-08-3110894475core:Non-currentFinancialInstrumentscore:AfterOneYear2025-08-3110894475core:Non-currentFinancialInstrumentscore:AfterOneYear2024-08-3110894475core:CurrentFinancialInstruments2025-08-3110894475core:CurrentFinancialInstruments2024-08-3110894475core:ShareCapital2025-08-3110894475core:ShareCapital2024-08-3110894475core:RetainedEarningsAccumulatedLosses2025-08-3110894475core:RetainedEarningsAccumulatedLosses2024-08-3110894475bus:Director12024-09-012025-08-3110894475core:Goodwill2024-09-012025-08-3110894475core:IntangibleAssetsOtherThanGoodwill2024-09-012025-08-3110894475core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2024-09-012025-08-3110894475core:LandBuildingscore:LongLeaseholdAssets2024-09-012025-08-3110894475core:FurnitureFittings2024-09-012025-08-3110894475core:ComputerEquipment2024-09-012025-08-3110894475core:MotorVehicles2024-09-012025-08-31108944752023-09-012024-08-3110894475core:Goodwill2024-08-3110894475core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2024-08-31108944752024-08-3110894475core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-08-3110894475core:FurnitureFittings2024-08-3110894475core:ComputerEquipment2024-08-3110894475core:MotorVehicles2024-08-3110894475core:LandBuildingscore:LeasedAssetsHeldAsLessee2025-08-3110894475core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-09-012025-08-3110894475core:Non-currentFinancialInstruments2025-08-3110894475core:Non-currentFinancialInstruments2024-08-3110894475core:WithinOneYear2025-08-3110894475core:WithinOneYear2024-08-3110894475core:BetweenTwoFiveYears2025-08-3110894475core:BetweenTwoFiveYears2024-08-3110894475bus:PrivateLimitedCompanyLtd2024-09-012025-08-3110894475bus:SmallCompaniesRegimeForAccounts2024-09-012025-08-3110894475bus:FRS1022024-09-012025-08-3110894475bus:AuditExemptWithAccountantsReport2024-09-012025-08-3110894475bus:FullAccounts2024-09-012025-08-31xbrli:purexbrli:sharesiso4217:GBP